DARE Dare Bioscience Inc.

1.08
+0.09  (+9%)
Previous Close 0.99
Open 1.09
Price To Book 1.01
Market Cap 12335934
Shares 11,422,161
Volume 1,090,301
Short Ratio 1.69
Av. Daily Volume 427,758

SEC filingsSee all SEC filings

  1. S-8 - Securities to be offered to employees in employee benefit plans 181025813
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 181013316
  3. 8-K - Current report 18949535
  4. 8-K - Current report 18900825
  5. 8-K - Current report 18873383

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b trial to be initiated 2H 2018.
SST-6007
Female Sexual Arousal Disorder (FSAD)